Page last updated: 2024-08-21

paeonol and Degenerative Diseases, Central Nervous System

paeonol has been researched along with Degenerative Diseases, Central Nervous System in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ge, QH; Li, Q; Ma, SP; Qu, R; Zhong, SZ1
Hsu, YY; Lo, YC; Shih, YT; Tseng, YT1

Other Studies

2 other study(ies) available for paeonol and Degenerative Diseases, Central Nervous System

ArticleYear
Paeonol attenuates neurotoxicity and ameliorates cognitive impairment induced by d-galactose in ICR mice.
    Journal of the neurological sciences, 2009, Feb-15, Volume: 277, Issue:1-2

    Topics: Acetylcholine; Acetylcholinesterase; Aging; Animals; Avoidance Learning; Cerebral Cortex; Cognition Disorders; Drugs, Chinese Herbal; Galactose; Glutathione; Hippocampus; Male; Malondialdehyde; Maze Learning; Mice; Mice, Inbred ICR; Neurodegenerative Diseases; Paeonia; Sodium-Potassium-Exchanging ATPase; Superoxide Dismutase

2009
Paeonol attenuates microglia-mediated inflammation and oxidative stress-induced neurotoxicity in rat primary microglia and cortical neurons.
    Shock (Augusta, Ga.), 2012, Volume: 37, Issue:3

    Topics: Acetophenones; Animals; Animals, Newborn; Anti-Inflammatory Agents; Cell Survival; Cells, Cultured; Cerebral Cortex; Cyclooxygenase 2; Female; Heme Oxygenase-1; Inflammation; Inflammation Mediators; Lipopolysaccharides; Microglia; Mitogen-Activated Protein Kinases; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Nitric Oxide Synthase Type II; Oxidative Stress; Oxidopamine; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxide Dismutase

2012